Drug Profile


Alternative Names: SCH-351125; SCH-C; Schering-C

Latest Information Update: 20 Aug 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Schering-Plough
  • Class Antiretrovirals; Cyclic N oxides; Piperidines; Pyridines
  • Mechanism of Action CCR5 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued HIV infections

Most Recent Events

  • 23 Feb 2004 Data presented at the 11th Conference on Retroviruses and Opportunistic Infections (CROI-2004) have been added to the pharmacokinetic and Viral infections therapeutic trials sections
  • 18 Mar 2002 A study has been added to the Viral Infections therapeutic trials, adverse events and pharmacokinetics sections
  • 19 Oct 2001 Phase-I clinical trials for HIV infections treatment in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top